GV29893 A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF MHAA4549A, A MONOCLONAL ANTIBODY, ADMINISTERED AS MONOTHERAPY FOR THE TREATMENT OF ACUTE UNCOMPLICATED SEASONAL INFLUENZA A INFECTION IN OTHERWISE HEALTHY ADULTS

Project: Research project

Project Details

StatusFinished
Effective start/end date10/27/16 → 10/26/18

Funding

  • Genentech, Inc.: $5,000.00